INNOCAN PHARMA Corp (INNPF) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate INNOCAN PHARMA Corp's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-19.52
Earnings Deficit
P/B Ratio
3.90
Strong
WeakModerateStrong
Earnings Yield
-5.15%
Yield Gap
Profitability Health
2025Return on Equity
-20.08%
Weak
WeakModerateStrong
Operating Margin
-4.72%
Weak
WeakModerateStrong
Net Profit Margin
-4.22%
Weak
WeakModerateStrong
Growth Indicators
2025Revenue Growth
-9.60%
Weak
WeakModerateStrong
Net Income Growth
38.71%
Strong
WeakModerateStrong
EPS Growth
40.48%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
7.70
Strong
WeakModerateStrong
Quick Ratio
6.09
Strong
WeakModerateStrong
Asset Turnover
2.53x
Strong
WeakModerateStrong
Inventory Turnover
1.23x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
2.19%
Weak
WeakModerateStrong
EV / Free Cash Flow
33.58x
Moderate
WeakModerateStrong
Net Debt / EBITDA
-44.28x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
-0.068
Weak
WeakModerateStrong
Return on Invested Capital
54.92%
Strong
WeakModerateStrong
Cash Conversion Cycle
277.61 days
Weak
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for INNPF.
View Financial Statements